Physician profile
Saima Athar
NPI 1811943343
$6,713.89
in general payments reported to CMS, 2019-2025
58 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,641 · 2020: $244 · 2021: $167 · 2022: $307 · 2023: $2,760 · 2024: $1,105 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,891 · Travel and Lodging: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,891.04 |
| Travel and Lodging | $1,462.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,629.05 | 2023-2025 | Inspire |
| Abbvie INC. | $594.11 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Ucb, INC. | $415.26 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Novartis Pharmaceuticals Corporation | $313.29 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $223.31 | 2019-2024 | Ajovy, Austedo Xr |
| Biogen, INC. | $220.51 | 2019-2025 | Vumerity, Spinraza |
| Alexion Pharmaceuticals, INC. | $211.48 | 2019-2024 | Ultomiris, Soliris |
| Acorda Therapeutics, INC | $194.81 | 2019-2024 | Inbrija |
| Amgen INC. | $180.76 | 2019-2023 | Aimovig |
| Avadel Cns Pharmaceuticals, LLC | $173.50 | 2024-2025 | Lumryz |
| Genzyme Corporation | $169.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $147.43 | 2019-2023 | Xywav |
| Harmony Biosciences LLC | $146.65 | 2023-2024 | Wakix |
| Tg Therapeutics, INC. | $126.18 | 2023-2025 | |
| Pfizer INC. | $112.02 | 2023-2025 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saima Athar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.